PCI Pharma Services, a global contract development and manufacturing organization (CDMO), has begun installation of key equipment for its newest sterile fill-finish facility on the company’s Bedford, NH campus. Twin lyophilizers and a state-of-the-art, large-scale isolator filling line are being installed at the forthcoming 50,000-square-foot plant, as foundational components of a previously announced, multi-year $100 million capital investment project. Additional equipment will be incorporated in the coming weeks.
